UBS Knock-Out VNA/ DE000UL1LMX2 /
18/06/2024 10:38:18 | Var.+0.010 | Denaro10:39:35 | Lettera10:39:35 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.930EUR | +1.09% | 0.920 Quantità in denaro: 25,000 |
0.930 Quantità in lettera: 25,000 |
VONOVIA SE NA O.N. | 35.5864 EUR | 31/12/2078 | Put |
GlobeNewswire
11:00
Hydrogen Powered Internal Combustion Engines are the Focus of a Live Webinar & White Paper
GlobeNewswire
11:00
Altus Formulation and Spektar Join Forces in New Specialty Company Spektus Pharma
GlobeNewswire
11:00
Future Health Index 2024 global report: Healthcare leaders turn to AI to address critical gaps in pa...
GlobeNewswire
10:30
Flash News: OKX Lists ZKsync's ZK Token on its Perpetual Futures Market, Expanding Trading Options
GlobeNewswire
10:01
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD ...
GlobeNewswire
10:00
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors w...
GlobeNewswire
10:00
FSLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fastly, Inc. Investors with Su...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
Nokia and Google Cloud collaborate to help developers worldwide create 5G applications faster with t...
GlobeNewswire
09:55
Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
GlobeNewswire
09:32
Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Smal...